Educational guide
Anastrozole and Rapamycin Interaction: Monitor | Peptide Database
Compound Profiles Anastrozole Aromatase Inhibitor | Estrogen Management Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Compound Profiles
Anastrozole
Aromatase Inhibitor | Estrogen Management
Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.
Rapamycin
mTOR Inhibitor | Longevity & Immunosuppression
Rapamycin exerts its effects by binding to the intracellular protein FKBP12, forming a complex that directly and specifically inhibits mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is a master nutrient-sensing kinase that integrates signals from growth factors, amino acids, energy status, and stress to regulate cell growth, proliferation, and metabolism.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Anastrozole with Rapamycin?
Yes, but with caution. Both Anastrozole and Rapamycin negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. Regular monitoring is advised.
Is Anastrozole and Rapamycin safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: lipid disrupting, teratogenic. Monitor accordingly.
What are the interactions between Anastrozole and Rapamycin?
Both Anastrozole and Rapamycin negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.
How should I time Anastrozole and Rapamycin?
Anastrozole has a half-life of ~40-50 hours and Rapamycin has a half-life of ~62 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.